Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Iatreia
versión impresa ISSN 0121-0793
Resumen
GARCIA-MONTOYA, Andrés José y BARRERA-ESCOBAR, Sebastián. Acute kidney injury and hemolytic anemia induced by rifampin, an infrequent and deadly complication. Iatreia [online]. 2022, vol.35, n.3, pp.356-360. Epub 19-Mayo-2023. ISSN 0121-0793. https://doi.org/10.17533/udea.iatreia.145.
Rifampicin is a widely used drug for the treatment of various infectious diseases with a broad spectrum of adverse reaction ranging from mild to life-threatening manifestations; hemolytic anemia is an adverse effect rarely reported in the literature, but it can have a potentially fatal outcome. Thus, we report a case of autoimmune hemolytic anemia associated with acute kidney injury in a young patient in the second phase of treatment for pulmonary tuberculosis.
Palabras clave : Acute Kidney Injury; Hemolysis; Rifampin.